Dare Bioscience, Inc. (DARE)

NASDAQ: DARE · IEX Real-Time Price · USD
1.19
-0.04 (-3.25%)
At close: Jul 1, 2022 4:00 PM
1.18
-0.01 (-0.84%)
After-hours: Jul 1, 2022 7:09 PM EDT

Cash Flow Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018201720162015201420132012 2011 - 2012
Net Income
-38.7-27.4-14.26-16.74-11.5-0.67-39.59-23.34-17.14-22.1
Upgrade
Depreciation & Amortization
-0.07-0.12-0.020.01000.190.130.20.35
Upgrade
Share-Based Compensation
1.60.740.460.140.020.012.380.890.620.53
Upgrade
Other Operating Activities
8.41.540.56.328.950.295.113.27-0.290.22
Upgrade
Operating Cash Flow
-28.76-25.23-13.32-10.27-2.54-0.37-31.92-19.06-16.61-21.01
Upgrade
Capital Expenditures
-0.01-0.020-0.0100-0.25-0.19-0.01-0.18
Upgrade
Acquisitions
006.14-0.519.9200000
Upgrade
Other Investing Activities
000000-0.23000
Upgrade
Investing Cash Flow
-0.01-0.026.14-0.529.920-0.48-0.19-0.01-0.18
Upgrade
Share Issuance / Repurchase
75.8524.765.1510.110039.81600.040
Upgrade
Debt Issued / Paid
00.37000.160.217.324.935.379.62
Upgrade
Other Financing Activities
00000000012.93
Upgrade
Financing Cash Flow
75.8525.135.1510.110.160.257.1364.935.422.55
Upgrade
Net Cash Flow
47-0.11-2.03-0.757.52-0.1724.7345.69-11.221.36
Upgrade
Free Cash Flow
-28.78-25.25-13.32-10.28-2.54-0.37-32.17-19.25-16.62-21.19
Upgrade
Free Cash Flow Margin
--------24057.50%-200.00%-3389.60%
Upgrade
Free Cash Flow Per Share
-0.47-0.84-0.85-0.96-0.79-0.45-12.65-13.23-242.88-347.67
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).